ACTB and inflammatory bowel disease: The expression levels of K2P5.1 relative to ACTB (in arbitrary units) were 0.0036 ± 0.0002 and 0.0161 ± 0.0025 in the splenic CD4+ T cells of control mice (n = 8) and IBD model mice (n = 6, P < 0.01), respectively.